HM Payson & Co’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-97
Closed -$26K 1133
2021
Q4
$26K Buy
+97
New +$26.1K ﹤0.01% 721
2021
Q2
Sell
-210
Closed -$41K 1151
2021
Q1
$41K Hold
210
﹤0.01% 633
2020
Q4
$40K Sell
210
-58
-22% -$10.6K ﹤0.01% 641
2020
Q3
$40K Buy
+268
New +$38.3K ﹤0.01% 601

Other funds holding RGEN

HM Payson & Co's RGEN Position: Q1 2022 in Review

HM Payson & Co sold out of Repligen (RGEN) in Q1 2022, closing a stake of 97 shares — an estimated $26K sold.

HM Payson & Co first reported a position in RGEN in Q3 2020 and held it in 4 quarters. The position peaked at $41K in Q1 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

  • HM Payson & Co reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
  • HM Payson & Co sold 97 Repligen shares in Q1 2022, an estimated $26K.
  • HM Payson & Co first reported a position in Repligen in Q3 2020 and held it in 4 quarters.
  • HM Payson & Co's Repligen position peaked at $41K in Q1 2021.
  • 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on HM Payson & Co's 13F filing for Q1 2022, filed 12 May 2022.